The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index‐2 (FI‐2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)
Open accessAbstract
The idiopathic inflammatory myopathies, including adult and juvenile dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune diseases that are characterized by chronic proximal muscle inflammation and weakness. In previous decades, there were few commonly used outcome measures in myositis, and those outcome measures were not validated. Thus, in the past the assessment of outcomes in therapeutic trials was focused on non-standardized measurement of muscle strength and function only. Over the last decade, however, two international collaborative groups, the International Myositis Assessment and Clinical Studies Group (IMACS) and the Paediatric Rheumatology International Trials Organisation (PRINTO), have defined consensus core set measures to assess myositis disease activity and damage in adults and children and have begun to validate and standardize these measures (1;2). IMACS and PRINTO have also developed preliminary definitions of improvement, which can be used as outcomes for therapeutic trials. These response criteria combine the core set activity measures to determine clinically meaningful improvement (3;4). Our section on myositis assessment focuses first on these core set measures of disease activity, quality of life (which is part of the PRINTO core set of activity, but a separate assessment domain for IMACS), and disease damage. To date, most of the validation data available for these core set measures are in patients with juvenile DM, with more limited validation in adult patients with DM or PM. Despite these efforts, there are still important gaps in validation of these core set measures, and no validation studies have yet been performed in patients with IBM, although they are now being used frequently in myositis therapeutic trials. We end the chapter with tools that have been used primarily in research studies and a few therapeutic trials, which have some supporting validation in certain subgroups of patients with myositis. These tools are primarily organ-specific measures, including strength and functional assessments and cutaneous assessment tools. Quantitative muscle testing and the IBM Functional Rating Scale are the most commonly used instruments to assess patients with IBM, and although they have little supporting validation in myositis, quantitative muscle testing has been well validated in other myopathies and has been used frequently as an endpoint in therapeutic trials for IBM. Although the methods for the assessment of myositis patients have been limited in their scope, great strides have been made in the last decade in the development of new partially validated tools (see Table 1) and international multidisciplinary consensus in using these measures that should enhance our understanding of the diverse effects of myositis on many organ systems and the development of new therapies. Table 1 Summary of Measures of Disease Activity in Myositis Physician and Patient/Parent Global Activity General Description Purpose An overall rating of the disease activity related to myositis, defined as potentially reversible pathology or physiology resulting from the underlying disease process (1).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychophysical bases of perceived exertion
BORG, G. A. V. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198205000-00012 · Cited by 16,580
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Pincus, T., Summey, J. A., Soraci, S. A., Wallston, K. A., & Hummon, N. P. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780261107 · Cited by 1,337
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
LEWIS-JONES, M. S., & FINLAY, A. Y. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb16953.x · Cited by 1,051
Hongbo, Y., Thomas, C. L., Harrison, M. A., Sam Salek, M., & Finlay, A. Y. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23621.x · Cited by 854
Measurement of health status in children with juvenile rheumatoid arthritis
Singh, G., Athreya, B. H., Fries, J. F., & Goldsmith, D. P. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371209 · Cited by 838
Basra, M. K. A., Fenech, R., Gatt, R. M., Salek, M. S., & Finlay, A. Y. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08832.x · Cited by 789
Chren, M.-M., Lasek, R. J., Quinn, L. M., Mostow, E. N., & Zyzanski, S. J. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12365600 · Cited by 699
(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068841 · Cited by 567
Varni, J. W., Seid, M., Smith Knight, T., Burwinkle, T., Brown, J., & Szer, I. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10095 · Cited by 535
Chren, M.-M. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890470111018 · Cited by 480
10 Years Experience of the Dermatology Life Quality Index (DLQI)
Lewis, V., & Finlay, A. Y. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.09113.x · Cited by 479
Chren, M.-M., Lasek, R. J., Sahay, A. P., & Sands, L. P. (2001) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/bf02737863 · Cited by 450
Chren, M. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.11.1433 · Cited by 446
(1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020045014 · Cited by 415
Isenberg, D. A., Allen, E., Farewell, V., Ehrenstein, M. R., Hanna, M. G., Lundberg, I. E., Oddis, C., Pilkington, C., Plotz, P., Scott, D., et al. (2004) · Rheumatology · doi:10.1093/rheumatology/keg427 · Cited by 368
Self-citationTreatment of inclusion-body myositis with IVIg: A double-blind, placebo-controlled study
Dalakas, M. C., Sonies, B., Dambrosia, J., Sekul, E., Cupler, E., & Sivakumar, K. (1997) · Neurology · doi:10.1212/wnl.48.3.712 · Cited by 350
Ruperto, N., Ravelli, A., Pistorio, A., Malattia, C., Cavuto, S., Gado-West, L., Tortorelli, A., Landgraf, J. M., Singh, G., & Martini, A. (2001) · PubMed · Cited by 337
Self-citationMiller, F. W. (2001) · Rheumatology · doi:10.1093/rheumatology/40.11.1262 · Cited by 332
Self-citationNordenskiöld, U. M., & Grimby, G. (1993) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749309095105 · Cited by 328
Critical Review of Generic and Dermatology-Specific Health-Related Quality of Life Instruments
Both, H., Essink-Bot, M.-L., Busschbach, J., & Nijsten, T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701142 · Cited by 327
Rahman, P., Gladman, D. D., Urowitz, M. B., Hallett, D., & Tam, L. S. (2001) · Lupus · doi:10.1191/096120301670679959 · Cited by 288
Ravelli, A., Trail, L., Ferrari, C., Ruperto, N., Pistorio, A., Pilkington, C., Maillard, S., Oliveira, S. K., Sztajnbok, F., Cuttica, R., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20015 · Cited by 279
Self-citationRider, L. G., Koziol, D., Giannini, E. H., Jain, M. S., Smith, M. R., Whitney‐Mahoney, K., Feldman, B. M., Wright, S. J., Lindsley, C. B., Pachman, L. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20035 · Cited by 277
Self-citationOutcome in patients with idiopathic inflammatory myositis: morbidity and mortality
Sultan, S. M., Ioannou, Y., Moss, K., & Isenberg, D. A. (2002) · Rheumatology · doi:10.1093/rheumatology/41.1.22 · Cited by 268
Self-citationDisease activity score for children with juvenile dermatomyositis: Reliability and validity evidence
Bode, R. K., Klein‐Gitelman, M. S., Miller, M. L., Lechman, T. S., & Pachman, L. M. (2003) · Arthritis Care & Research · doi:10.1002/art.10924 · Cited by 257
Escolar, D. M., Henricson, E. K., Mayhew, J., Florence, J., Leshner, R., Patel, K. M., & Clemens, P. R. (2001) · Muscle & Nerve · doi:10.1002/mus.1070 · Cited by 251
Lovell, D. J., Lindsley, C. B., Rennebohm, R. M., Ballinger, S. H., Bowyer, S. L., Giannini, E. H., Hicks, J. E., Levinson, J. E., Mier, R. J., Pachman, L. M., et al. (1999) · Arthritis & Rheumatism · Cited by 245
Self-citationHuber, A. M., Feldman, B. M., Rennebohm, R. M., Hicks, J. E., Lindsley, C. B., Perez, M. D., Zemel, L. S., Wallace, C. A., Ballinger, S. H., Passo, M. H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20179 · Cited by 239
Self-citationQuantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis
Maillard, S. M. (2004) · Rheumatology · doi:10.1093/rheumatology/keh130 · Cited by 238
Ruperto, N. (2003) · Rheumatology · doi:10.1093/rheumatology/keg403 · Cited by 234
Self-citationA controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM
Dalakas, M. C., Koffman, B., Fujii, M., Spector, S., Sivakumar, K., & Cupler, E. (2001) · Neurology · doi:10.1212/wnl.56.3.323 · Cited by 233
International consensus on preliminary definitions of improvement in adult and juvenile myositis
Rider, L. G., Giannini, E. H., Brunner, H. I., Ruperto, N., James‐Newton, L., Reed, A. M., Lachenbruch, P. A., & Miller, F. W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20349 · Cited by 229
Self-citation(1988) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068256 · Cited by 218
Shikiar, R., Willian, M. K., Okun, M. M., Thompson, C. S., & Revicki, D. A. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-71 · Cited by 210
Dermatology quality of life scales -a measure of the impact of skin diseases
MORGAN, M., McCREEDY, R., SIMPSON, J., & HAY, R. J. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.d01-1169.x · Cited by 197
Defining Clinical Improvement in Adult and Juvenile Myositis.
Rider, L. G., Giannini, E. H., Harris‐Love, M. O., Joe, G. O., Isenberg, D. A., Pilkington, C., Lachenbruch, P. A., & Miller, F. W. (2003) · PubMed · Cited by 183
Self-citationYu, C. H. (2005) · Encyclopedia of Social Measurement · doi:10.1016/b0-12-369398-5/00094-3 · Cited by 180
Badia, Mascaró, Lozano, & ON BEHALF OF THE CAVIDE RESEARCH GROUP (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03112.x · Cited by 170
de Korte, J., Mombers, F. M. C., Sprangers, M., & Bos, J. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.9.1221 · Cited by 167
Maximum voluntary isometric contraction: Reference values and clinical application
Meldrum, D., Cahalane, E., Conroy, R. M., Fitzgerald, D., & Hardiman, O. M. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960601012491 · Cited by 162
Ruperto, N., Ravelli, A., Pistorio, A., Ferriani, V., Calvo, I., Ganser, G., Brunner, J., Dannecker, G., Silva, C. A., Stanevicha, V., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23248 · Cited by 160
Self-citationFunctional outcome and quality of life in adult patients with idiopathic inflammatory myositis
Ponyi, A., Borgulya, G., Constantin, T., Váncsa, A., Gergely, L., & Dankó, K. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh404 · Cited by 159
Rider, L. G., Lachenbruch, P. A., Monroe, J. B., Ravelli, A., Cabalar, I., Feldman, B. M., Villalba, M. L., Myones, B. L., Pachman, L. M., Rennebohm, R. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24904 · Cited by 158
Self-citationBenefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis
Alexanderson, H., Dastmalchi, M., Esbjörnsson, M., Opava, C. H., & Lundberg, I. E. (2007) · Arthritis Care & Research · doi:10.1002/art.22780 · Cited by 155
Self-citationRider, L. G., Miller, F. W., Feldman, B. M., Perez, M. D., Rennebohm, R. M., Lindsley, C. B., Zemel, L. S., Wallace, C. A., Ballinger, S. H., Bowyer, S. L., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401109 · Cited by 155
Self-citationOpava, C. H. (2000) · Scandinavian Journal of Rheumatology · doi:10.1080/030097400447679 · Cited by 155
Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
Jackson, C. E., Barohn, R. J., Gronseth, G., Pandya, S., Herbelin, L. L., & The Muscle Study Group (MSG) (2008) · Muscle & Nerve · doi:10.1002/mus.20958 · Cited by 152
Self-citationTesting and Reducing Skindex-29 Using Rasch Analysis: Skindex-17
Nijsten, T. E. C., Sampogna, F., Chren, M., & ABENI, D. D. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700212 · Cited by 150
The Children's Dermatology Life Quality Index: validation of the cartoon version
Holme, S. A., Man, I., Sharpe, J., Dykes, P. J., Lewis‐Jones, M. S., & Finlay, A. Y. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05157.x · Cited by 141
Maximal Isometric Muscle Strength: Normative Values and Gender-Specific Relation to Age
Stoll, T., Huber, E., Seifert, B., Michel, B. A., & Stucki, G. (2000) · Clinical Rheumatology · doi:10.1007/s100670050026 · Cited by 141
Huber, A. M., Giannini, E. H., Bowyer, S. L., Kim, S., Lang, B. A., Lindsley, C. B., Pachman, L. M., Pilkington, C., Reed, A. M., Rennebohm, R. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20071 · Cited by 139
Self-citationHarris‐Love, M. O., Shrader, J. A., Koziol, D. E., et al. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken441 · Cited by 132
Personius, K. E., Pandya, S., King, W. M., Tawil, R., McDermott, M., & The FSH DY Group (1994) · Physical Therapy · doi:10.1093/ptj/74.3.253 · Cited by 131
(1997) · Neurology · doi:10.1212/wnl.48.1.38 · Cited by 131
Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study
Alexanderson, H. (1999) · British journal of rheumatology · doi:10.1093/rheumatology/38.7.608 · Cited by 126
Self-citationChren, M., Lasek, R. J., Quinn, L., & Covinsky, K. E. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285650 · Cited by 123
Reliability and validity of the myositis disease activity assessment tool
Sultan, S. M., Allen, E., Oddis, C. V., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23963 · Cited by 122
Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life
Hundley, J. L., Carroll, C. L., Lang, W., Snively, B. M., Yosipovitch, G., Feldman, S. R., & Jorizzo, J. L. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.12.015 · Cited by 122
DeVellis, R. F. (2005) · Encyclopedia of Social Measurement · doi:10.1016/b0-12-369398-5/00095-5 · Cited by 120
Inclusion body myositis: old and new concepts
Amato, A. A., & Barohn, R. J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.173823 · Cited by 116
Self-citationQuality of life in dermatomyositis
Goreshi, R., Chock, M., Foering, K., Feng, R., Okawa, J., Rose, M., Fiorentino, D. F., & Werth, V. P. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.10.016 · Cited by 116
Self-citationSanner, H., Gran, J. T., Sjaastad, I., & Flatø, B. (2009) · Rheumatology · doi:10.1093/rheumatology/kep302 · Cited by 114
A pilot randomized trial of oxandrolone in inclusion body myositis
Rutkove, S. B., Parker, R. A., Nardin, R. A., Connolly, C. E., Felice, K. J., & Raynor, E. M. (2002) · Neurology · doi:10.1212/wnl.58.7.1081 · Cited by 103
International research networks in pediatric rheumatology: the PRINTO perspective
Ruperto, N., & Martini, A. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000130286.54383.ea · Cited by 99
Self-citationFacioscapulohumeral muscular dystrophy (FSHD)
Tawil, R., McDermott, M. P., Mendell, J. R., Kissel, J. T., Griggs, R. C., & FSH-DY Group (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.442 · Cited by 98
A functional index in myositis.
Josefson, A., Romanus, E., & Carlsson, J. (1996) · PubMed · Cited by 96
Ruperto, N., Pistorio, A., Ravelli, A., Rider, L. G., Pilkington, C., de Oliveira, S. K. F., Wulffraat, N. M., Espada, G., Garay, S. M., Cuttica, R. J., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20280 · Cited by 94
Self-citationClarke, A. E., Bloch, D. A., Medsger, T. A., & Oddis, C. V. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380907 · Cited by 92
Alexanderson, H., Lundberg, I. E., & Stenström, C. H. (2002) · PubMed · Cited by 88
Self-citationAlexanderson, H., Broman, L., Tollbäck, A., Josefson, A., Lundberg, I. E., & Opava, C. H. (2006) · Arthritis Care & Research · doi:10.1002/art.21715 · Cited by 81
Self-citationMeasurement of body surface area involvement in atopic eczema: an impossible task?
Charman, Venn, & Williams, H. C. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02617.x · Cited by 81
Randomized pilot trial of high-dose βINF-1a in patients with inclusion body myositis
The Muscle Study Group (2004) · Neurology · doi:10.1212/01.wnl.0000134675.98525.79 · Cited by 79
Randomized pilot trial of βINF1a (Avonex) in patients with inclusion body myositis
The Muscle Study Group* (2001) · Neurology · doi:10.1212/wnl.57.9.1566 · Cited by 77
Categorization of Skindex-29 Scores Using Mixture Analysis
Nijsten, T. E. C., Sampogna, F., & ABENI, D. D. (2008) · Dermatology · doi:10.1159/000182253 · Cited by 76
Sanner, H., Kirkhus, E., Merckoll, E., Tollisen, A., Røisland, M., Lie, B. A., Taraldsrud, E., Gran, J. T., & Flatø, B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20203 · Cited by 76
Huber, A. M., Dugan, E. M., Lachenbruch, P. A., Feldman, B. M., Perez, M. D., Zemel, L. S., Lindsley, C. B., Rennebohm, R. M., Wallace, C. A., Passo, M. H., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23340 · Cited by 73
Self-citationRegardt, M., Henriksson, E. W., Alexanderson, H., & Lundberg, I. E. (2010) · Rheumatology · doi:10.1093/rheumatology/keq356 · Cited by 71
Self-citationA prospective natural history study of inclusion body myositis
Rose, M. R., McDermott, M. P., Thornton, C. A., Palenski, C., Martens, W. B., & Griggs, R. C. (2001) · Neurology · doi:10.1212/wnl.57.3.548 · Cited by 69
Takken, T. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg210 · Cited by 67
Apaz, M. T., Saad‐Magalhães, C., Pistorio, A., Ravelli, A., Sato, J. D. O., Marcantoni, M., Meiorin, S., Filocamo, G., Pilkington, C., Maillard, S. M., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24343 · Cited by 61
Self-citationMeasurement of Isometric Force in Children with and without Duchenne's Muscular Dystrophy
Brussock, C. M., Haley, S. M., Munsat, T. L., & Bernhardt, D. B. (1992) · Physical Therapy · doi:10.1093/ptj/72.2.105 · Cited by 55
What determines quality of life in inclusion body myositis?
Sadjadi, R., Rose, M. R., & Muscle Study Group (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183863 · Cited by 54
Huber, A. M., Dugan, E. M., Lachenbruch, P. A., Feldman, B. M., Perez, M. D., Zemel, L. S., Lindsley, C. B., Rennebohm, R. M., Wallace, C. A., Passo, M. H., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem179 · Cited by 54
Self-citationRandomized pilot trial of βINF1a (Avonex) in patients with inclusion body myositis
(2002) · Neurology · doi:10.1212/wnl.58.2.334 · Cited by 51
Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM
Goreshi, R., Okawa, J., Rose, M., Feng, R., Lee, L. A., Hansen, C. B., Bangert, C. A., Connolly, M. K., Davis, M. D. P., Callen, J. P., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.440 · Cited by 50
Self-citationNormal scores for nine maneuvers of the Childhood Myositis Assessment Scale
Rennebohm, R. M., Jones, K. B., Huber, A. M., Ballinger, S. H., Bowyer, S. L., Feldman, B. M., Hicks, J. E., Katona, I. M., Lindsley, C. B., Miller, F. W., et al. (2004) · Arthritis Care & Research · doi:10.1002/art.20397 · Cited by 49
Self-citationInterrater reliability and aspects of validity of the myositis damage index
Sultan, S. M., Allen, E., Cooper, R. G., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142117 · Cited by 49
Dermatology Life Quality Index: influence of an illustrated version
Loo, W. J., Diba, V. C., Chawla, M. K., et al. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05158.x · Cited by 48
Huber, A. M., Lachenbruch, P. A., Dugan, E. M., Miller, F. W., Rider, L. G., & For the Juvenile Dermatomyositis Disease Activity Collaborative Study Group (2008) · Arthritis Care & Research · doi:10.1002/art.23313 · Cited by 42
Self-citationJain, M., Smith, M., Cintas, H. M., Koziol, D. E., WESLEY, R. A., Harris‐Love, M. O., Lovell, D., Rider, L. G., & Hicks, J. E. (2006) · Physical & Occupational Therapy In Pediatrics · doi:10.1080/j006v26n03_02 · Cited by 30
Self-citationQuality of life in juvenile idiopathic arthritis patients compared to healthy children
Martini, A., & Ruperto, N. (2001) · Clinical and Experimental Rheumatology S.A.S. eBooks · Cited by 24
Self-citationPreedy, V. R., & WATSON, R. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_6554 · Cited by 9
Cited by
Current Classification and Management of Inflammatory Myopathies
Schmidt, J. (2018) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180308 · Cited by 324
Immune-Mediated Necrotizing Myopathy
Pinal-Fernandez, I., Casal-Dominguez, M., & Mammen, A. L. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0732-6 · Cited by 297
Dover, S., Stephens, S., Schneiderman, J. E., Pullenayegum, E., Wells, G. D., Levy, D. M., Marcuz, J.-A., Whitney, K., Schulze, A., Tein, I., et al. (2021) · The Journal of Rheumatology · doi:10.3899/jrheum.191375 · Cited by 18
Metadata
- Authors
- Rider, L. G., Werth, V. P., Huber, A. M., Alexanderson, H., Rao, A. P., Ruperto, N., Herbelin, L., Barohn, R., Isenberg, D., & Miller, F. W.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2011-11
- Volume
- 63
- Issue
- S11
- Pages
- S118-57
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W1578458646
- Cited by
- 430
- References
- 96
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.